Literature DB >> 26567116

End-of-life decision-making of terminally ill cancer patients in a tertiary cancer center in Shanghai, China.

Xiaoli Gu1,2, Menglei Chen1,2, Minghui Liu1,2, Zhe Zhang1,2, Wenwu Cheng3,4.   

Abstract

PURPOSE: Different countries have various decision-making practices, which are formalized according to laws, rules, traditions, religious beliefs, and ethical views of different cultural backgrounds. We investigated the characteristics and factors associated with the decision-making details in terminally ill cancer patients in a tertiary cancer center in Shanghai, China.
METHOD: A single center, retrospective study was performed among advanced cancer patients who died between March 2007 and December 2013 in ward at Palliative Care Unit, Fudan University Shanghai Cancer Center.
RESULTS: Of 436 patients' end-of-life (EOL) discussions, 424 (97.2 %) occurred between family caregivers and physicians. The main decision-maker was in the following order: spouse (45.6 %), offsprings (44.3 %), parents (3.2 %), son-/daughter-in-law (1.8 %), and relatives (1.4 %). Two hundred twenty-one (47.3 %) patients received at least one of six life-sustaining treatments. One hundred eighty-four (40.4 %) patients continued artificial nutrition and hydration (ANH) until death. Cardiopulmonary resuscitation (CPR) was performed in 26 patients (6.0 %). Two hundred fourteen (49.1 %) patients received vasopressors before death. Only two patients received mechanical ventilation and only one patient received tracheostomy. The median time interval since the decision made till death was 20.17 h (95 % CI = 18.94-21.40, range 4.3 to 70.2 h). Patients who were older than 65 years old were less likely to undergo an intensive procedure (AOR = 0.559, 95 % CI = 0.367-0.852, p = 0.007). Patients living in urban settings (AOR = 2.177, 95 % CI = 1.398-3.390, p = 0.001) were more likely to undergo an intensive procedure in the EOL period.
CONCLUSIONS: This study reflected some Chinese characteristics for decision-making at the end of life among advanced cancer patients. More prospective studies focused on specific EOL issues are required to improve the quality of EOL care.

Entities:  

Keywords:  Decision-making; End-of-life; Life-sustaining treatment; Palliative care

Mesh:

Year:  2015        PMID: 26567116     DOI: 10.1007/s00520-015-3017-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  26 in total

Review 1.  Understanding beliefs and meanings in the experience of cancer: a concept analysis.

Authors:  M C Richer; H Ezer
Journal:  J Adv Nurs       Date:  2000-11       Impact factor: 3.187

2.  End-of-life care in the general wards of a Singaporean hospital: an Asian perspective.

Authors:  Jason Phua; Adrian Chin-Leong Kee; Adeline Tan; Amartya Mukhopadhyay; Kay Choong See; Ngu Wah Aung; Angeline S T Seah; Tow Keang Lim
Journal:  J Palliat Med       Date:  2011-11-07       Impact factor: 2.947

3.  End-of-life care discussions in patients with advanced cancer.

Authors:  Pallavi Kumar; Jennifer S Temel
Journal:  J Clin Oncol       Date:  2013-07-29       Impact factor: 44.544

4.  Is patient autonomy a critical determinant of quality of life in Korea? End-of-life decision making from the perspective of the patient.

Authors:  Ha Na Mo; Dong Wook Shin; Jae Ha Woo; Jin Young Choi; Jina Kang; Young Ji Baik; Yu Rae Huh; Joo Hee Won; Myung Hee Park; Sang Hee Cho
Journal:  Palliat Med       Date:  2011-05-11       Impact factor: 4.762

5.  International differences in end-of-life attitudes in the intensive care unit: results of a survey.

Authors:  Arino Yaguchi; Robert D Truog; J Randall Curtis; John M Luce; Mitchell M Levy; Christian Mélot; Jean-Louis Vincent
Journal:  Arch Intern Med       Date:  2005-09-26

6.  Information needs and preferences for participation in treatment decisions among Swedish breast cancer patients.

Authors:  B Wallberg; H Michelson; M Nystedt; C Bolund; L F Degner; N Wilking
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

7.  Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan.

Authors:  T Y Chiu; W Y Hu; C Y Chen
Journal:  Support Care Cancer       Date:  2000-07       Impact factor: 3.603

8.  Family consent, communication, and advance directives for cancer disclosure: a Japanese case and discussion.

Authors:  A Akabayashi; M D Fetters; T S Elwyn
Journal:  J Med Ethics       Date:  1999-08       Impact factor: 2.903

9.  A survey of the perspectives of patients who are seriously ill regarding end-of-life decisions in some medical institutions of Korea, China and Japan.

Authors:  Kwon Ivo; Koh Younsuck; Yun Young Ho; Suh Sang-Yeon; Heo Dae Seog; Bae Hyunah; Hattori Kenji; Zhai Xiaomei
Journal:  J Med Ethics       Date:  2012-01-17       Impact factor: 2.903

10.  End-of-life decision-making in six European countries: descriptive study.

Authors:  Agnes van der Heide; Luc Deliens; Karin Faisst; Tore Nilstun; Michael Norup; Eugenio Paci; Gerrit van der Wal; Paul J van der Maas
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

View more
  10 in total

1.  Participation in treatment decision-making among Chinese-Australian women with breast cancer.

Authors:  Cannas Kwok; Fung Kuen Koo
Journal:  Support Care Cancer       Date:  2016-11-18       Impact factor: 3.603

2.  Patient participation in treatment decision-making of prostate cancer: a qualitative study.

Authors:  Shucheng Pan; Jinjiao Mao; Lijuan Wang; Yun Dai; Wei Wang
Journal:  Support Care Cancer       Date:  2022-01-27       Impact factor: 3.603

3.  The Association between End-of-Life Care and the Time Interval between Provision of a Do-Not-Resuscitate Consent and Death in Cancer Patients in Korea.

Authors:  Sun Kyung Baek; Hye Jung Chang; Ja Min Byun; Jae Joon Han; Dae Seog Heo
Journal:  Cancer Res Treat       Date:  2016-09-01       Impact factor: 4.679

4.  C-reactive protein and white blood cell count are adverse prognostic markers for patients with advanced cancer on parenteral nutrition in a palliative care unit setting: A retrospective cohort study.

Authors:  Markus Kieler; Paul Kössler; Matija Milovic; Elias Meyer; Kristína Križanová; Lea Kum; Alexander Friedrich; Eva Masel; Raimund Bauer; Matthias Unseld
Journal:  Palliat Med       Date:  2022-02-20       Impact factor: 4.762

Review 5.  Conceptualizing and Counting Discretionary Utilization in the Final 100 Days of Life: A Scoping Review.

Authors:  Paul R Duberstein; Michael Chen; Michael Hoerger; Ronald M Epstein; Laura M Perry; Sule Yilmaz; Fahad Saeed; Supriya G Mohile; Sally A Norton
Journal:  J Pain Symptom Manage       Date:  2019-10-19       Impact factor: 3.612

6.  Knowledge, attitudes, and influencing factors of cancer patients toward approving advance directives in China.

Authors:  Ru-Jun Zheng; Yan Fu; Qiu-Fen Xiang; Mei Yang; Lin Chen; Ying-Kang Shi; Chun-Hua Yu; Jun-Ying Li
Journal:  Support Care Cancer       Date:  2016-05-21       Impact factor: 3.603

Review 7.  Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review.

Authors:  Tao Wang; Alex Molassiotis; Betty Pui Man Chung; Jing-Yu Tan
Journal:  BMC Palliat Care       Date:  2018-07-23       Impact factor: 3.234

8.  Supporting the patients with advanced cancer and their family caregivers: what are their palliative care needs?

Authors:  Gek Phin Chua; Grace Su Yin Pang; Alethlea Chung Pheng Yee; Patricia Soek Hui Neo; Siqin Zhou; Cindy Lim; Yin Yee Wong; Debra Limin Qu; Fang Ting Pan; Grace Meijuan Yang
Journal:  BMC Cancer       Date:  2020-08-15       Impact factor: 4.430

9.  "We Want to Sign It, But We Can't Do It": Results From a Qualitative Pilot Study of Experiences Related to Advance Directives Among Families of Older Residents in a Long-term Care Facility.

Authors:  Hsin-Tzu Sophie Lee; Chia-Ling Yang; Ting-Ru Chen; Sei-Ven Leu; Wen-Yu Hu
Journal:  J Hosp Palliat Nurs       Date:  2021-12-01       Impact factor: 1.918

10.  Discussion of advance care planning on end-of-life decisions with lung cancer patients in Wuhan, China: attitude, timing and future directions.

Authors:  Liya Hu; Qian Chu; Zeng Fan; Yuan Chen
Journal:  Intern Med J       Date:  2021-12       Impact factor: 2.611

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.